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Strength training increases walking tolerance
in intermittent claudication patients:
Randomized trial
Raphael Mendes Ritti-Dias, PhD,a,b Nelson Wolosker, PhD,c Cláudia Lúcia de Moraes Forjaz, PhD,b
Celso Ricardo Fernandes Carvalho, PhD,d Gabriel Grizzo Cucato, BS,b Pedro Puech Leão, PhD,c and
Maria de Fátima Nunes Marucci, PhD,e Pernambuco and São Paulo, Brazil
Objective: To analyze the effects of strength training (ST) in walking capacity in patients with intermittent claudication
(IC) compared with walking training (WT) effects.
Methods: Thirty patients with IC were randomized into ST and WT. Both groups trained twice a week for 12 weeks at the
same rate of perceived exertion. ST consisted of three sets of 10 repetitions of whole body exercises. WT consisted of 15
bouts of 2-minute walking. Before and after the training program walking capacity, peak VO2, VO2 at the first stage of
treadmill test, ankle brachial index, ischemic window, and knee extension strength were measured.
Results: ST improved initial claudication distance (358 224 vs 504 276 meters; P< .01), total walking distance (618
282 to 775  334 meters; P < .01), VO2 at the first stage of treadmill test (9.7  2.6 vs 8.1  1.7 mL · kg1 · minute;
P< .01), ischemic window (0.81 1.16 vs 0.43 0.47 mm Hg minute meters1; P .04), and knee extension strength (19
 9 vs 21 8 kg and 21 9 vs 23 9; P< .01). Strength increases correlated with the increase in initial claudication distance
(r  0.64; P  .01) and with the decrease in VO2 measured at the first stage of the treadmill test (r  0.52; P  .04 and r
 0.55; P  .03). Adaptations following ST were similar to the ones observed after WT; however, patients reported lower
pain during ST than WT (P < .01).
Conclusion: ST improves functional limitation similarly to WT but it produces lower pain, suggesting that this type of
exercise could be useful and should be considered in patients with IC. (J Vasc Surg 2010;51:89-95.)Intermittent claudication (IC) is the most prevalent
symptom of peripheral arterial disease. It is caused by a
reduction of arterial oxygen delivery to the lower leg during
exercise,1 resulting in functional limitations2 and reduced
quality of life.3
Supervised exercise of walking training (WT) is cur-
rently recommended as the first-line therapy for patients
with IC.1,2 To promote greater improvements, WT should
be performed at an intensity that elicits claudication pain.1,2
However, pain during exercise sessions may reduce treat-
ment adherence.4 Thus, another form of exercise that
elicits the same benefits with lower or no pain is desirable
for these patients.
Positive correlation between knee extension strength
and walking tolerance has been found in patients with IC,5
suggesting that interventions that improve leg strength
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doi:10.1016/j.jvs.2009.07.118might increase exercise tolerance in these patients. More-
over, since patients with IC present muscle atrophy,6-8
altered skeletal muscle phenotype,9 and reduced leg
strength,5,8,10,11 strength training (ST) might be a success-
ful intervention in these patients.
Only a few studies have addressed the role of ST in
patients with IC. After 12 weeks of lower body ST, im-
provement in initial claudication distance (ICD)12 and
total walking distance (TWD)12,13 were observed. In addi-
tion, only one study13 compared the effects of ST with
those produced by WT, which is considered the best mode
of exercise for patients with IC. In that study, greater
increases in walking distances were observed with WT than
with ST. However, WT and ST programs had different
durations and intensities, which might have affected the
results. Moreover, the levels of pain during WT and ST
have not been studied.
Therefore, the main objective of this study was to
analyze the effects of 12 weeks of ST on exercise tolerance
in patients with IC, comparing its effects with those ob-
served with WT. Moreover, we compared the intensity of
pain during ST and WT sessions. We hypothesized that ST
would improve exercise tolerance similarly to WT; how-
ever, it would cause less pain during exercise sessions.
METHODS
Patient recruitment and screening. This study was
approved by the Joint Committee on Ethics of Human
Research of the Public Health of the University of São
Paulo (process 1370/05). Each patient was informed of
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written informed consent before participation. This study
was registered in the www.clinicaltrials.gov and the regis-
tration number is NCT00879697.
From July 2005 to December 2006, 300 patients with
IC who were enrolled in a tertiary center specialized in
vascular disease and were able to walk for at least 2 minutes
at 2 miles per hour (mph), were invited to a meeting at
which explanations about this study were given. Eighty
patients attended the meeting, 60 of them decided to take
part in the study, and 52 attended for the screening tests.
Patients were included in the study if they met the
following criteria: Fontaine stage II peripheral arterial dis-
ease,14 symptoms of IC for at least 6 months, ankle brachial
index (ABI) at rest 0.90 in 1 or 2 legs, reduction of ABI
after treadmill test, and exercise tolerance limited by IC.
Patients were excluded under the following conditions:
presence of chronic lung disease, inability to obtain ABI
measurement due to noncompressible vessels, exercise tol-
erance limited by factors other than claudication (eg, dys-
pnea or orthopedic problems), poorly controlled blood
pressure, presence of electrocardiogram response sugges-
tive of myocardial ischemia during the exercise test, and
history of revascularization in the previous year. Seven
patients did not present symptoms of claudication during
the treadmill test, 5 presented electrocardiogram response
suggestive of myocardial ischemia, 4 presented exercise
tolerance limited by other factors than claudication, and 2
presented poorly controlled blood pressure. None of these
patients were included in the study. A total of 34 patients
were considered eligible for the study.
Procedures. Patients were randomly divided into 2
groups: strength (ST, n  17) and walking (WT, n  17)
training. Randomization was performed by computer ran-
dom number generation (www.randomizer.org). They
were evaluated at baseline (pre-training) and after 12 weeks
of exercise training (post-training) by a physician who was
blinded to the exercise program performed by patients.
Exercise tolerance and strength were assessed during eval-
uations.
Exercise test. Patients performed a progressive-graded
cardiopulmonary treadmill test until maximal claudication
pain, as previously described for these patients.15 All pa-
tients were already familiarized with the test protocol be-
fore the experiments. During the test, an electrocardiogram
was continuously monitored and registered at the end of
each stage. Oxygen uptake (VO2) was continuously mea-
sured by a metabolic cart (Medical Graphics Corp CPX/D,
St Paul, Minn), and VO2 was averaged every minute for
analysis. Peak VO2 was defined as the highest VO2 achieved
during the treadmill test.
ICD and TWD were defined, respectively, as the dis-
tance walked when the patient first reported pain in the leg,
and the distance at which the patient was unable to con-
tinue to exercise due to leg pain. These procedures resulted
in reliability coefficient (r) of 0.89 for ICD,15 0.93 for
TWD,15 and 0.88 for peak VO2.
16Walking economy was analyzed based on the VO2
measured during the last minute of the first stage of the
treadmill test (2 mph without inclination).17
Ankle brachial index and ischemic window. Systolic
brachial blood pressure was obtained by auscultation using
a mercury sphygmomanometer. Systolic ankle blood pres-
sure was measured by Doppler ultrasound (Martec DV
6000, Ribeirão Preto, Brazil). These procedures were em-
ployed based on a previous study that observed similar
results between auscultatory and Doppler scan methods in
the assessment of brachial blood pressure.18 Ankle blood
pressure was measured in the dorsalis pedis artery and
posterior tibial artery, and the higher of these two pressures
in each leg was recorded as the resting ankle systolic pres-
sure. Blood pressure measurements were obtained after
patients rested in the supine position for at least 20 minutes
before and at 1, 3, 5, and 7 minutes after the progressive-
graded treadmill test used to assess claudication distances
and peak VO2.
The ABI was calculated for each leg as the quotient
between systolic ankle and brachial blood pressures, and
the value of the worst leg was used in the sample descrip-
tion. The ischemic window was calculated using rest and
recovery ankle blood pressure as previously described.19
Briefly, the reduction in ankle systolic blood pressure after
the treadmill test from the resting value was quantified by
calculating the area under the curve. Since the ischemic
window is affected by the total amount of exercise per-
formed, its value was divided by TWD to normalize it for
meters walked in the treadmill test.
Maximal leg strength. Maximal concentric strength
was evaluated by the 1 repetitionmaximal (1RM) test using
unilateral knee extension exercise.20 Briefly, after 10 sub-
maximal repetitions for warming-up, the workload was
gradually increased subjectively until the patient could not
lift the load more than once. Three to 5 trials were per-
formed with 1 to 2 minutes of recovery between them.
Before the 1RM test, patients performed four familiariza-
tion sessions, conducted with the same protocol as the
maximal strength test.
Exercise training programs. Both training programs
(ST and WT) consisted of two sessions per week during 12
weeks. ST and WT were conducted by two exercise physi-
ologists, who supervised 4 patients in each training session.
In both programs, rate of perceived exertion during exer-
cise was kept between 11 to 13 on the 15-grade Borg
scale.21 Furthermore, ST and WT training sessions lasted
approximately 60 minutes, consisting of 30 minutes of
exercise and 30 minutes of passive recovery.
The WT program was performed using a treadmill. In
each session, patients performed fifteen 2-minute bouts of
exercise followed by a 2-minute rest interval between them.
Walking speed was set in order to induce perceived exertion
of 11 to 13, and claudication pain in the last 30 seconds of
each exercise bout.
The ST program consisted of eight exercises performed
on specific ST machines (Biodelta, São Paulo, Brazil) in the
following order: leg press, crunches, unilateral knee exten-
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 1 Ritti-Dias et al 91sion, seated row, unilateral knee flexion, seated bench press,
calf raises on leg press, and seated back extension. ST was
performed in a set sequence, employing three sets of 10
repetitions with a 2-minute interval between sets and be-
tween exercises.
Speed (for WT) or weights (for ST) were adjusted in
the next set or bout every time perceived exertion was,
respectively, lower or higher than 11 and 13 on the 15-
grade Borg scale.21
Physical activity performed between exercise sessions
was not controlled. However, patients were instructed to
maintain their previous physical activity levels throughout
the study.
Assessment of pain during training. In training ses-
sion number 22 (ie, week 11), the level of the patient’s
perceived pain during exercise was assessed using a vali-
dated self-rated visual analog scale.22 This session was
chosen because patients were already adapted to training.
The visual analog scale included a 10-cm long ungraduated
line representing the severity of pain marked at its ends with
0 and 10 (0 no pain and 10 unbearable pain). Patients
were instructed to indicate in the scale how much pain they
were experiencing during each set in ST, and in each bout
of walking inWT group. Themean pain during the walking
session and the mean pain during upper arm and lower leg
strength exercises were calculated.
Statistical analysis. The sample size was statistically
calculated based on data from a previous study13 to pro-
duce a power of 80% and an  error of 5%. A total number
of 16 (8 in each group) and 26 subjects (13 in each group)
were needed to detect differences between groups in ICD
(75%  65%) and TWD (38%  45%), respectively.
Normality and homogeneity of variance of data were
confirmed by Shapiro-Wilks and Levene tests, respectively.
The 2 test was used to compare gender, risk factors, and
medication prevalence between groups. The independent t
test was used to compare groups for the following: contin-
uous variables at baseline, duration of exercise training
sessions, and intensity of pain during the training session.
The effect of training in both groups were assessed by
two-way analysis of variance (ANOVA) (time group) for
repeated measures. When significance was obtained, New-
man-Keuls post hoc test was used to identify the differ-
ences. Pearson correlation was used to evaluate the rela-
tionship between knee extension strength changes and
other parameter changes and Spearman correlation was
used to evaluate the relationship between pain levels and
the rate of perceived exertion. The significance level was set
at P  .05. Data are presented as mean  standard devia-
tion.
RESULTS
Seventeen subjects were randomized to each training
group. However, 4 patients (2 in ST and 2 in WT) did not
complete the training programs for the following reasons:
inguinal hernia (n  1), gastrointestinal infection (n  1),
ongoing treatment for lung cancer (n  1), and diagnosisof abdominal aneurysm (n  1). Therefore, 30 patients
completed the study (ST  15 and WT  15).
Pre-training clinical characteristics were similar in ST
and WT groups, and are presented in Table I. In both
groups, patients were mostly elderly, male, overweight
nonsmokers or ex-smokers, and were receiving antihyper-
tensive and antiplatelet medications.
Adherence to exercise training was similar between ST
and WT groups (95%  5% and 94%  5%, respectively;
P  .98). Furthermore, the duration of exercise sessions
was also similar between ST andWT (67.4 4.5 and 68.6
3.6 minutes, respectively; P  .91).
In the pre-training test, exercise performance variables
were similar between ST and WT groups (Table II). The
ICD and TWD increased significantly (P  .05) and simi-
larly during the study in both groups (P  .01). The
distance walked while in pain (TWD – ICD) did not change
significantly in either group (ST  259  192 vs 271 
205 meters, and WT  230  135 vs 252  116 meters,
P .82). The VO2 at the first stage of the treadmill test and
ischemic window improved significantly and similarly dur-
ing the study in both groups (P .05). Neither group had
significant change in peak VO2 after the exercise programs
(P  .05). Only the ST group increased knee extension
strength in both legs (P  .01).
Correlation matrix between knee extension strength
change and changes in exercise-related variables observed
in the patients undergoing ST are presented in Table III.
Strength increase obtained in the leg with higher ABI,
presented a significant and positive correlation with the
increase in ICD (r  0.64; P  .01). Strength increases
observed in the leg with lower ABI and in both legs
presented significant and negative correlations with VO2
Table I. Clinical characteristics of the studied patients
before strength (n  15) and walking training (n  15)
Strength
training
Walking
training P
Age (years) 65.7 (9.5) 64.5 (8.8) .72
Gender (% men) 73.3 60.0 .35
ABI in the worst leg 0.63 (0.12) 0.66 (0.13) .80
Bilateral disease 66.7 60.0 .50
Ileo-femoral 20.0 26.7 .50
Femoro-popliteal 40.0 46.7 .50
Tibio-fibular 40.0 26.7 .35
Risk factors
Physical activity (% inactive) 60.0 47.7 .36
Actual smoker (%) 13.3 33.3 .20
Hypertension (%) 86.7 93.3 .50
Diabetes mellitus (%) 26.7 40.0 .35
Obesity (%) 26.7 33.3 .50
Heart disease (%) 26.7 20.0 .50
Medications
	-blocker (%) 40.0 53.3 .36
Antihypertensive agent (%) 86.7 80.0 .50
Statin 53.3 40.0 .36
Antiplatelet agent (%) 80.0 80.0 .67
Cilostazol (%) 13.3 6.7 .50measured at the first stage of the treadmill test (r0.52;
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correlation with walking economy. In neither leg did
strength improvement correlated with the change in TWD
and VO2 peak.
Self-rated pain reported during ST and WT are pre-
sented in the Fig. Patients in the ST group reported higher
pain levels during lower-body than during upper-body
exercises (1.5 1.2 vs 1.0 0.9; P .02). Nevertheless, in
comparison with pain reported during WT (2.9  1.2),
lower and upper body strength exercises elicited signifi-
cantly lower pain levels (P  .01).
DISCUSSION
The major findings of this investigation were: (1) ST
Table II. Performance variables in patients with intermitt
training (n  15)
Pre-t
Initial claudication distance (meters)
Strength training 358
Walking training 342
Total walking distance (meters)
Strength training 618
Walking training 572
Peak VO2 (ml · kg
1 · min1)
Strength training 16.1
Walking training 14.3
VO2 at the first stage of treadmill test (ml · kg
1 · min1)
Strength training 9.7
Walking training 9.8
Ischemic window (mm Hg · min · m1)
Strength training 0.81
Walking training 0.31
Strength in leg with lower ABI (kg)
Strength training 19
Walking training 18
Strength in leg with higher ABI (kg)
Strength training 21
Walking training 21
ABI, Ankle brachial index.
aSignificant difference from pre-training.
Table III. Linear relationship between improvement in
strength and changes in exercise responses in patients
with intermittent claudication submitted to strength
training (n  15)

 Strength
leg with
lower ABI

 Strength
leg with
higher ABI

 Sum
strength of
both legs

 Initial claudication
distance 0.28 0.64a 0.48

 Total walking distance 0.02 0.07 0.01

 VO2 at the first stage of
treadmill test 0.52a 0.43 0.55a

 Peak VO2 0.01 0.07 0.01
ABI, Ankle brachial index.
aSignificant correlation (P  .05).improved walking tolerance in patients with IC, (2) gains instrength after ST are correlated with improvements in ICD
and walking economy, (3) adaptations after ST were similar
to those observed with WT with similar frequency, dura-
tion, and rate of perceived exertion, and (4) during ST,
patients reported less pain than during WT.
Although ST might be a useful therapy in patients with
IC, who present muscle dysfunction and reduction in lower
leg strength that compromise walking capacity,1,2 few pre-
vious studies12,13 have investigated ST efficacy in these
patients. The present study showed that 12 weeks of ST for
the whole body, performed twice a week at a submaximal
intensity based on perceived exertion, increases both ICD
and TWD in patients with IC. A similar ST program in
patients with IC (exercise for the whole body, two sets of 8
to 15 repetitions maximum, three times/week) produced
significant increases in ICD and in TWD.12 On the other
hand, a different training program (six lower leg exercises,
sets of six maximal repetitions using cuff weights, three
times/week) produced an increase only in TWD.13 Some
methodologic characteristics of the present study might
explain the greater improvements observed: (1) more sub-
jects, (2) the involvement of whole body (not just lower leg
exercises), (3) more exercises, and (4) the use of machines
instead of cuff weights. These differences suggest that a
general protocol including more exercises for the whole
body might promote greater adaptation. Nevertheless,
comparisons between different ST protocols were out of
the scope of the present study and have not been studied
yet.
The possible mechanisms underlying the increase in
exercise tolerance after ST in patients with IC remain
laudication submitted to strength (n  15) or walking
ng Post-training Group effect Time effect Interaction effect
) 504 (276)a 0.75 0.01 0.72
) 469 (237)a
) 775 (334)a 0.63 0.01 0.85
) 721 (289)a
15.8 (3.6) 0.57 0.31 0.88
14.1 (2.8)
8.1 (1.7)a 0.24 0.01 0.81
8.4 (0.7)a
) 0.43 (0.47)a 0.12 0.04 0.20
) 0.20 (0.22)a
21 (8)a 0.49 0.82 0.01a
16 (8)
23 (9)a 0.46 0.07 0.01a
20 (9)ent c
raini
(224
(182
(282
(231
(4.3)
(2.9)
(2.6)
(1.6)
(1.16
(0.52
(9)
(8)
(9)
(9)poorly understood. In the present study, there was a signif-
leg p
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cle strength and the improvement in ICD. Pain during
walking in patients with IC has been attributed to the
ischemic process caused by arterial obstruction, which
blocks the oxygen supply required by muscle demand dur-
ing exercise. Thus, an increase in pain-free distance after ST
might be a result of an increase in oxygen supply to the
muscle, and/or of a decrease in walking oxygen cost,
delaying the occurrence of ischemia. Since changes in lower
leg strength are also correlated with walking economy, our
results suggest that, at least partly, the decrease in oxygen
cost for walking is a mechanism responsible for the increase
in ICD after ST training. The improvement in walking
economy and its relationship with walking tolerance has
already been reported after WT in patients with IC23 and
after ST in older subjects,24 but our study is the first to
demonstrate it in patients with IC after ST. This improve-
ment might be a result of several factors, such as an increase
in capillarity, changes in muscle fibers properties, and an
increase in mitochondrial content. However, the explora-
tion of these mechanisms was out of the scope of this study
and should be the target of future investigations.
Interestingly, strength improvement did not correlate
with an increase in TWD or distance walked while in pain.
Since the onset of ischemia reflects the metabolic acidosis in
skeletal muscle and an increase in the predominance of
anaerobic metabolism, these results suggest that training
did not improve muscle tolerance to acidosis and walking
capacity under anaerobic metabolism.
After the ST program, there was a decrease in the
ischemic window, showing that ST resulted in decreased
magnitude and/or duration of ischemia after a single bout
of walking exercise. The decrease in the ischemic window
has been systematically described after WT,23,25,26 but this
Fig. Self rated pain during exercise sessions in strength tr
a Significant greater than ST upper (P  .05). b Signific
included: crunches, seated row, seated bench press, and se
knee extension, unilateral knee flexion, and calf raises onis the first study to show this effect after ST. The decrease inischemic window suggests an improvement in muscle
reperfusion of lower extremities after exercise,26,27 which
may be caused by an improvement in endothelial func-
tion.28 Nevertheless, McDermott et al29 did not find any
effect of ST on reactive hyperemia in patients with periph-
eral arterial disease. However, these authors investigated
patients with and without IC together, and endothelial
dysfunction might be greater in patients with IC,30 favor-
ing a greater training effect in these patients. Moreover,
these authors employed only lower leg ST and did not
report any changes in time to claudication with ST. In other
populations with chronic disease, such as patients with
heart failure, 3 months of ST have been reported to im-
prove reactive hyperemia.31
There is a considerable body of evidence confirming
the efficacy of WT in improving exercise performance and
quality of life of patients with IC. The percentage of in-
creases in walking distances in the present study were lower
than previously reported.2 Several factors might explain this
controversy. First, the patients enrolled in the present study
had a higher walking capacity at baseline. Therefore, the
analysis of improvements in relative changes might have
masked the results.32 In fact, when analyzing the absolute
changes, the improvements in walking capacity after WT
were similar to the ones reported in literature.2,29 Second,
the exercise protocol used in this study was based on
perceived exertion, instead of on claudication symptoms.1,2
As the achievement of maximal pain has been considered
important for greater training adaptation, the low pain
levels observed in this study might also explain the lower
relative improvements observed in relation to the literature.
However, the prescription based on perceived exertion
allowed the comparison between ST and WT keeping
similar training overload (frequency, duration, and inten-
g (ST) (dark bar) and walking training (WT) (white bar).
reater than ST lower (P  .01). Upper body exercises
back. Lower body exercises included: leg press, unilateral
ress.ainin
ant g
atedsity). Thus, the present results indicated that STmight be as
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duration, and at the same perceived exertion.
Pain during exercise is an important issue for patients
with IC. We are not aware of any previous study reporting
pain during ST sessions in patients with IC. In the present
study, patients undergoing ST reported lower levels of pain
during upper- than during lower-body exercises, showing
that ST exercise also produced ischemia when the affected
leg was involved in the effort. During WT, pain scores were
relatively low (2.9  1.2 in a 10 point scale), which might
reflect prescription based on low perceived exertion (11-
13), since there was a significant correlation between pain
score and perceived exertion (P  .66; P  .001) during
WT. Nevertheless, the important finding of the present
study was that with similar perceived exertion, ST pro-
moted lower pain (almost 50%). A recent study showed that
pain during exercise is one of the most frequent barriers for
exercise practice in patients with peripheral arterial disease.4
This has also been reported in patients with other dis-
eases.33 Nevertheless, in the present study, adherence rates
were similar between ST and WT groups; however, the
specific characteristics of this study (relative short duration,
very closely supervised exercise, and telephone calls after
missing sessions) might have affected these results. Future
studies should address the specific effects of pain levels
during exercise on treatment adherence and maintenance
of patients with IC.
There were several limitations in the present study. Our
sample was composed of patients with many diseases, tak-
ing different medications, with unilateral or bilateral dis-
ease, and also with atherosclerotic lesions in different sites.
However, as these aspects were not different between
groups in the pre-training condition, it is not probable that
they had a significant impact on the results.Moreover, since
IC is closely linked to many chronic diseases, the exclusion
of patients under these conditions would have reduced the
clinical applicability of our data.
CONCLUSION
ST increases exercise tolerance in patients with IC.
These increases were similar than ones observed after WT.
However, ST increased muscle strength and caused less
pain during exercise sessions. These results show the effi-
cacy of ST in improving functional limitation in patients
with IC, suggesting that it could be considered for these
patients.
The authors are grateful to Andrew Gardner and Fer-
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The authors report a randomized trial comparing the benefits
of strength training (ST) and walking training (WT) in patients
with intermittent claudication. The study uses standard outcome
measures to objectively quantify improvements in ambulation and
physiological function, including walking distance, oxygen con-
sumption, walking economy, ischemic window, and leg strength.
It also raises questions about the underlying cause of exercise-
induced discomfort and the value of potential new therapeutic
alternatives.
The authors modified previously reported exercise therapy
protocols, proposing another possible option for the treatment of
claudication. It is becoming clear from basic science studies1 and
clinical trials2 that significant abnormalities are present in the lower
extremity musculature, leading to altered gait. The authors suc-
cinctly point to these abnormalities as a justification for the use of
ST to improve ambulatory function. The exact nature of the
abnormalities, and their effect on gait, is becomingmore evident as
information accumulates from recent large-scale studies docu-
menting the presence of a lower extremity strength deficit in
patients with peripheral arterial disease (PAD).3 Advanced biome-
chanical analyses are also beginning to delineate the contribution
of individual muscle groups to the gait abnormalities associated
with PAD in a limited number of patients.2,4
In contrast to previous studies that have relied on a predeter-
mined level of ambulatory effort, and to compare ST and WT, the
current protocol uses perceived exertion measured by the validated
Borg scale to determine therapeutic effort. This approach is new
within the supervised exercise literature; however, perceived exer-
tion in exercise provides a relatively stable measure of work unre-
lated to objective measurements, especially in elite athletes.5 Inter-
estingly, patients in the current study had a perceived exertion thatOmaha, Neb
suggesting a potential need to standardize patient effort in future
trials.
Although the current results demonstrate significant improve-
ment in ambulation with both protocols, to conclude that ST is
comparable to WT from these results and those of related studies
would be inappropriate. Despite previously well-designed and
executed trials comparing supervisedWTwith ST, very little can be
concluded based on the significant variations in conduct and
outcome measures. The current study, in the context of recent
literature, clearly illustrates the need for standardization. For the
field of PAD treatment to progress, common outcome measures
need to be agreed upon and reported to allow for accurate com-
parisons among the myriad of medical, exercise, and operative
treatments available.
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